The Net Margin of Halozyme Therapeutics Inc (HALO) is 43.74%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 43.74% |
2023-12-31 | 33.96% |
2022-12-31 | 30.62% |
2021-12-31 | 90.84% |
2020-12-31 | 48.24% |
2019-12-31 | -36.84% |
2018-12-31 | -52.86% |
2017-12-31 | 19.90% |
2016-12-31 | -70.21% |
2015-12-31 | -23.83% |